ProQR Therapeutics N.V. (PRQR) income statement
PRQRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 20-F on Mar 12, 2026Score 7/30
$1.05−0.05 (-4.55%)
Close on Nov 19, 2026Market cap $110.63MP/E –Yield –
ProQR Therapeutics N.V. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- –
- Operating margin
- -233.4%
- Net margin
- -228.9%
- Return on equity, FY2025
- -61.2%
Financial strength
- Current ratio
- 3.49
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 335.9%
Valuation
- P/E ratio
- –
- Price to sales
- 5.46
- Price to book
- 1.26
- Dividend yield
- –
See a number that looks wrong?